Methyldopa was first patented in the United States on March 27, 1956. The patent, U.S. Patent 2,741,647, was granted to Merck & Co. [1].
When did methyldopa patent protection expire?
Patent protection for methyldopa has long expired. While the initial patent was granted in 1956, drug patents typically last for a set term, and older patents would have concluded their protection periods many years ago. Information on the exact expiration dates of all related patents can be found on DrugPatentWatch.com [1, 2].
What is methyldopa used for?
Methyldopa is a medication used to treat high blood pressure, also known as hypertension [3]. It is often prescribed during pregnancy when other blood pressure medications are not suitable [4].
How does methyldopa work to lower blood pressure?
Methyldopa is an alpha-2 adrenergic agonist. It works by stimulating alpha-2 receptors in the brainstem. This stimulation reduces sympathetic outflow from the central nervous system to the heart and blood vessels, leading to a decrease in heart rate, blood pressure, and peripheral resistance [3, 5].
Are there generic versions of methyldopa available?
Yes, generic versions of methyldopa are available. Because its original patents have expired, other pharmaceutical companies are able to manufacture and market the drug, making it more accessible and affordable [1, 2].
What are the common side effects of methyldopa?
Common side effects of methyldopa include drowsiness, dizziness, headache, and dry mouth. Some individuals may also experience gastrointestinal issues like nausea or constipation [3, 6].
What is the difference between methyldopa and other blood pressure medications?
Methyldopa belongs to a class of medications known as centrally acting alpha-2 adrenergic agonists. This mechanism of action differs from other common blood pressure medications such as ACE inhibitors, beta-blockers, or calcium channel blockers, which target different pathways to lower blood pressure [3, 5]. Its safety profile, particularly during pregnancy, distinguishes it from many other antihypertensive agents [4].
Who manufactures methyldopa?
Since the expiration of its original patents, methyldopa is manufactured by various pharmaceutical companies globally, including those producing generic medications [1, 2].
What are the risks associated with methyldopa use?
Potential risks associated with methyldopa include side effects such as sedation, and in rare cases, liver problems or hemolytic anemia. It is important for patients to discuss their medical history and any concerns with their healthcare provider before starting methyldopa [3, 6].
Sources:
[1] DrugPatentWatch.com
[2] https://www.drugpatentwatch.com/
[3] https://www.nhs.uk/medicines/methyldopa/
[4] https://www.mayoclinic.org/drugs-supplements/methyldopa-oral-route/proper-use/drg-20067472
[5] https://www.ncbi.nlm.nih.gov/books/NBK557800/
[6] https://www.webmd.com/drugs/2/drug-20067472/methyldopa-oral/details